ImmunologybioRxiv
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
B. Carter, P. Huang, G. Liu…·D. K. Gifford
A T cell vaccine based on conserved epitopes protects HLA transgenic mice from SARS-CoV-2 Beta variant mortality without inducing neutralizing antibodies.
DOI 10.3389/fimmu.2023.1135815